---
layout: default
title: Unsupervised Deep Generative Models for Anomaly Detection in Neuroimaging: A Systematic Scoping Review
---

# Unsupervised Deep Generative Models for Anomaly Detection in Neuroimaging: A Systematic Scoping Review

**arXiv**: [2510.14462v1](https://arxiv.org/abs/2510.14462) | [PDF](https://arxiv.org/pdf/2510.14462.pdf)

**ä½œè€…**: Youwan MahÃ©, Elise Bannier, StÃ©phanie Leplaideur, Elisa Fromont, Francesca Galassi

---

## ðŸ’¡ ä¸€å¥è¯è¦ç‚¹

**ç»¼è¿°æ— ç›‘ç£æ·±åº¦ç”Ÿæˆæ¨¡åž‹åœ¨ç¥žç»å½±åƒå¼‚å¸¸æ£€æµ‹ä¸­çš„åº”ç”¨ä¸Žè¿›å±•**

**å…³é”®è¯**: `æ— ç›‘ç£å­¦ä¹ ` `æ·±åº¦ç”Ÿæˆæ¨¡åž‹` `ç¥žç»å½±åƒå¼‚å¸¸æ£€æµ‹` `ä¼ªå¥åº·é‡å»º` `è„‘éƒ¨MRI` `ç»¼è¿°ç ”ç©¶`

## ðŸ“‹ æ ¸å¿ƒè¦ç‚¹

1. æ ¸å¿ƒé—®é¢˜ï¼šç›‘ç£æ–¹æ³•ä¾èµ–å¤§é‡æ ‡æ³¨æ•°æ®ï¼Œéš¾ä»¥å¤„ç†ç½•è§æˆ–å¼‚è´¨æ€§ç–¾ç—…ã€‚
2. æ–¹æ³•è¦ç‚¹ï¼šä½¿ç”¨å¥åº·æ•°æ®è®­ç»ƒç”Ÿæˆæ¨¡åž‹ï¼Œæ£€æµ‹å¼‚å¸¸ä½œä¸ºä¸Žè§„èŒƒç»“æž„çš„åå·®ã€‚
3. å®žéªŒæˆ–æ•ˆæžœï¼šæ¨¡åž‹åœ¨å¤§åž‹å±€ç¶æ€§ç—…å˜ä¸­è¡¨çŽ°è‰¯å¥½ï¼Œå¹¶ç”Ÿæˆå¯è§£é‡Šçš„ä¼ªå¥åº·é‡å»ºã€‚

## ðŸ“„ æ‘˜è¦ï¼ˆåŽŸæ–‡ï¼‰

> Unsupervised deep generative models are emerging as a promising alternative
> to supervised methods for detecting and segmenting anomalies in brain imaging.
> Unlike fully supervised approaches, which require large voxel-level annotated
> datasets and are limited to well-characterised pathologies, these models can be
> trained exclusively on healthy data and identify anomalies as deviations from
> learned normative brain structures. This PRISMA-guided scoping review
> synthesises recent work on unsupervised deep generative models for anomaly
> detection in neuroimaging, including autoencoders, variational autoencoders,
> generative adversarial networks, and denoising diffusion models. A total of 49
> studies published between 2018 - 2025 were identified, covering applications to
> brain MRI and, less frequently, CT across diverse pathologies such as tumours,
> stroke, multiple sclerosis, and small vessel disease. Reported performance
> metrics are compared alongside architectural design choices. Across the
> included studies, generative models achieved encouraging performance for large
> focal lesions and demonstrated progress in addressing more subtle
> abnormalities. A key strength of generative models is their ability to produce
> interpretable pseudo-healthy (also referred to as counterfactual)
> reconstructions, which is particularly valuable when annotated data are scarce,
> as in rare or heterogeneous diseases. Looking ahead, these models offer a
> compelling direction for anomaly detection, enabling semi-supervised learning,
> supporting the discovery of novel imaging biomarkers, and facilitating within-
> and cross-disease deviation mapping in unified end-to-end frameworks. To
> realise clinical impact, future work should prioritise anatomy-aware modelling,
> development of foundation models, task-appropriate evaluation metrics, and
> rigorous clinical validation.

